AMGN Amgen Inc
- Stocks
- Healthcare
- NASDAQ: AMGN
Price (delayed)
$286.48
Market cap
$154.23B
P/E Ratio
23.25
Dividend/share
$9.26
EPS
$12.32
Enterprise value
$202.41B
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.
Highlights
The net income has soared by 111% YoY and by 12% from the previous quarter
AMGN's EPS has surged by 111% year-on-year and by 11% since the previous quarter
Key stats
What are the main financial stats of AMGN
Market
Valuations
Earnings
Shares outstanding
538.36M
Market cap
$154.23B
Enterprise value
$202.41B
Price to earnings (P/E)
23.25
Price to book (P/B)
20.74
Price to sales (P/S)
4.41
EV/EBIT
19.53
EV/EBITDA
12.74
EV/Sales
5.8
Revenue
$34.92B
Gross profit
$22.52B
Operating income
$8.19B
Net income
$6.62B
EBIT
$10.36B
EBITDA
$15.89B
Free cash flow
$10.61B
Per share
Balance sheet
Liquidity
EPS
$12.32
EPS diluted
$12.23
Free cash flow per share
$19.71
Book value per share
$13.81
Revenue per share
$64.9
TBVPS
$82.92
Total assets
$87.9B
Total liabilities
$80.47B
Debt
$56.2B
Equity
$7.43B
Working capital
$6.26B
Debt to equity
7.57
Current ratio
1.31
Quick ratio
0.82
Net debt/EBITDA
3.03
Margins
Efficiency
Dividend
EBITDA margin
45.5%
Gross margin
64.5%
Net margin
19%
Operating margin
23.5%
Return on assets
7.4%
Return on equity
97.9%
Return on invested capital
14.4%
Return on capital employed
15.4%
Return on sales
29.7%
Dividend yield
3.23%
DPS
$9.26
Payout ratio
75.2%
AMGN stock price
How has the Amgen stock price performed over time
Intraday
0.53%
1 week
0.64%
1 month
-2.98%
1 year
-11.43%
YTD
9.91%
QTD
2.6%
Financial performance
How have Amgen's revenue and profit performed over time
Revenue
$34.92B
Gross profit
$22.52B
Operating income
$8.19B
Net income
$6.62B
Gross margin
64.5%
Net margin
19%
The net income has soared by 111% YoY and by 12% from the previous quarter
The net margin has surged by 88% year-on-year and by 9% since the previous quarter
AMGN's operating income is up by 32% year-on-year and by 10% since the previous quarter
The company's operating margin rose by 18% YoY and by 8% QoQ
Price vs fundamentals
How does AMGN's price correlate with its fundamentals
Growth
What is Amgen's growth rate over time
Valuation
What is Amgen stock price valuation
P/E
23.25
P/B
20.74
P/S
4.41
EV/EBIT
19.53
EV/EBITDA
12.74
EV/Sales
5.8
AMGN's EPS has surged by 111% year-on-year and by 11% since the previous quarter
The P/E is 27% below the last 4 quarters average of 31.5 and 8% below the 5-year quarterly average of 25.2
The stock's price to book (P/B) is 32% less than its 5-year quarterly average of 30.2 and 12% less than its last 4 quarters average of 23.5
Amgen's equity has increased by 25% YoY and by 20% from the previous quarter
The P/S is 14% less than the 5-year quarterly average of 5.1 and 7% less than the last 4 quarters average of 4.7
The revenue has grown by 13% year-on-year and by 2.3% since the previous quarter
Efficiency
How efficient is Amgen business performance
AMGN's return on assets has surged by 118% year-on-year and by 14% since the previous quarter
The ROE has soared by 94% YoY and by 5% from the previous quarter
The ROIC has soared by 62% YoY and by 7% from the previous quarter
AMGN's return on sales is up by 36% year-on-year and by 4.6% since the previous quarter
Dividends
What is AMGN's dividend history
DPS
$9.26
Dividend yield
3.23%
Payout ratio
75.2%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Amgen financials performed over time
Amgen's total assets is 9% more than its total liabilities
Amgen's current ratio has increased by 12% from the previous quarter and by 4% YoY
AMGN's quick ratio is up by 11% since the previous quarter and by 9% year-on-year
AMGN's debt to equity is down by 28% YoY and by 18% QoQ
Amgen's equity has increased by 25% YoY and by 20% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.